Qualipoly Chemical Corp.
TWSE:4722.TW
43.3 (TWD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,454.793 | 4,224.68 | 4,830.426 | 3,822.858 | 4,292.615 | 4,748.831 | 4,950.532 | 4,655.443 | 4,505.223 | 4,996.442 | 4,858.179 | 4,856.385 | 4,118.452 | 3,296.004 | 2,428.689 |
| Cost of Revenue
| 2,927.08 | 3,462.414 | 3,824.508 | 3,062.726 | 3,568.45 | 4,043.957 | 4,179.427 | 3,810.591 | 3,662.265 | 4,396.647 | 4,303.531 | 4,300.193 | 3,709.678 | 2,956.163 | 2,150.598 |
| Gross Profit
| 527.713 | 762.266 | 1,005.918 | 760.132 | 724.165 | 704.874 | 771.105 | 844.852 | 842.958 | 599.795 | 554.648 | 556.192 | 408.774 | 339.841 | 278.091 |
| Gross Profit Ratio
| 0.153 | 0.18 | 0.208 | 0.199 | 0.169 | 0.148 | 0.156 | 0.181 | 0.187 | 0.12 | 0.114 | 0.115 | 0.099 | 0.103 | 0.115 |
| Reseach & Development Expenses
| 50.169 | 53.373 | 55.122 | 49.965 | 51.605 | 55.145 | 47.053 | 43.924 | 40.321 | 37.272 | 32.722 | 26.694 | 21.045 | 21.394 | 23.42 |
| General & Administrative Expenses
| 118.953 | 121.734 | 127.158 | 104.913 | 102.018 | 107.88 | 106.238 | 111.571 | 109.659 | 103.288 | 99.946 | 102.615 | 82.113 | 72.225 | 64.157 |
| Selling & Marketing Expenses
| 198.96 | 263.837 | 343.547 | 252.254 | 234.779 | 238.99 | 259.154 | 267.099 | 268.307 | 259.046 | 269.555 | 263.349 | 189.128 | 159.186 | 119.192 |
| SG&A
| 311.643 | 385.571 | 470.705 | 357.167 | 336.797 | 346.87 | 365.392 | 378.67 | 377.966 | 362.334 | 369.501 | 365.964 | 271.241 | 231.411 | 183.349 |
| Other Expenses
| 0 | 83.19 | 18.743 | 27.963 | 11.025 | 55.312 | 13.282 | 6.457 | 18.7 | 38.587 | 44.939 | 8.353 | 1.063 | 1.347 | -5.686 |
| Operating Expenses
| 361.812 | 438.944 | 525.827 | 407.132 | 388.402 | 402.015 | 412.445 | 422.594 | 418.287 | 399.606 | 402.223 | 392.658 | 292.286 | 252.805 | 206.769 |
| Operating Income
| 165.901 | 407.973 | 499.99 | 382.174 | 346.788 | 302.859 | 358.66 | 422.258 | 424.671 | 200.189 | 152.425 | 163.534 | 116.488 | 87.036 | 71.322 |
| Operating Income Ratio
| 0.048 | 0.097 | 0.104 | 0.1 | 0.081 | 0.064 | 0.072 | 0.091 | 0.094 | 0.04 | 0.031 | 0.034 | 0.028 | 0.026 | 0.029 |
| Total Other Income Expenses Net
| 46.949 | 72.575 | -17.127 | -15.476 | -8.254 | 48.392 | 6.167 | 1.644 | 8.053 | 26.909 | 31.394 | 60.092 | 12.68 | 6.357 | -7.789 |
| Income Before Tax
| 212.85 | 401.366 | 482.863 | 366.698 | 338.534 | 351.251 | 364.827 | 423.902 | 432.724 | 227.098 | 183.819 | 223.626 | 129.168 | 93.393 | 63.533 |
| Income Before Tax Ratio
| 0.062 | 0.095 | 0.1 | 0.096 | 0.079 | 0.074 | 0.074 | 0.091 | 0.096 | 0.045 | 0.038 | 0.046 | 0.031 | 0.028 | 0.026 |
| Income Tax Expense
| 45.824 | 86.323 | 115.056 | 85.38 | 81.826 | 97.395 | 69.659 | 80.209 | 85.12 | 48.324 | 43.781 | 40.849 | 23.3 | 13.045 | 19.709 |
| Net Income
| 167.026 | 315.043 | 367.807 | 281.318 | 256.708 | 253.856 | 295.168 | 343.693 | 347.604 | 178.774 | 140.038 | 182.777 | 105.868 | 80.348 | 43.824 |
| Net Income Ratio
| 0.048 | 0.075 | 0.076 | 0.074 | 0.06 | 0.053 | 0.06 | 0.074 | 0.077 | 0.036 | 0.029 | 0.038 | 0.026 | 0.024 | 0.018 |
| EPS
| 1.67 | 3.15 | 3.73 | 2.83 | 2.57 | 2.54 | 2.95 | 3.5 | 3.75 | 1.93 | 1.55 | 2.41 | 1.39 | 1.17 | 0.67 |
| EPS Diluted
| 1.67 | 3.14 | 3.73 | 2.83 | 2.56 | 2.53 | 2.95 | 3.5 | 3.74 | 1.92 | 1.54 | 2.4 | 1.39 | 1.17 | 0.67 |
| EBITDA
| 289.332 | 470.865 | 563.318 | 444.178 | 406.03 | 363.843 | 428.891 | 486.68 | 506.983 | 265.389 | 264.03 | 304.385 | 186.3 | 151.453 | 132.521 |
| EBITDA Ratio
| 0.084 | 0.111 | 0.117 | 0.116 | 0.095 | 0.088 | 0.087 | 0.105 | 0.113 | 0.061 | 0.054 | 0.048 | 0.045 | 0.046 | 0.054 |